Healthcare

Biopharmaceutical Market Size is Predicted to Reach US$ 856.1 billion by 2030

Share This Article

The global biopharmaceutical market size is forecasted to reach from US$ 297.19 billion in 2021 to US$ 856.1 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 12.5% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 and 2020, the forecast period considered is from 2021 to 2030. The biopharmaceutical market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1422

The rising prevalence of various chronic diseases, growing geriatric population, rising investments in the research and development of the new drugs, supportive regulations of the government, and rising adoption of the biopharmaceuticals among the global population are some of the important factors that drives the growth of the global biopharmaceutical market.

The biopharmaceutical market is growing at a rapid rate and it accounts for around 20% of the global pharmaceutical industry. The increasing awareness about the effectiveness and availability of the biopharmaceuticals among the population is significantly boosting the demand for the biopharmaceuticals across the globe.

Scope of the Biopharmaceutical Market Report

Report Coverage Details
Market Size in 2021 USD 297.19 Billion
Growth Rate CAGR of 12.5% From 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, Application, Region

Competitive Landscape Analysis:

Some of the leading companies operating in the biopharmaceutical market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Major companies operating in this report are

  • Abbott Laboratories
  • Amgen, Inc.
  • Biogen, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche, Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Sanofi

Market Dynamics

Driver

Rising demand for the low side-effect treatment

Traditionally, the treatment of the various chronic diseases were risky and resulted in adverse side-effects. For instance, the conventional chemotherapy was toxic and has high side-effects. The development of the improved biopharmaceuticals provided a safer alternative to such traditional therapeutics and increasing awareness regarding the benefits of the biopharmaceuticals over the traditional therapeutics is expected to drive the market growth.

Restraints

High cost of medicines and lack of adequate healthcare infrastructure

The high costs of the innovative biopharmaceuticals is restricting its adoption among the people in the low and middle income countries due to the low affordability. Moreover, the lack of proper healthcare infrastructure results in under-treatment. This is major factor that may hinder the growth of the global biopharmaceutical market during the forecast period.

Opportunities

New product launches and adoption of developmental strategies

The biopharmaceutical industry is fragmented owing to the presence of numerous big players. It is a rapidly growing market and has higher threat of the new market entrants. The various developmental strategies such as new product launches, partnerships, collaborations, and join ventures may have a positive impact on the market. For instance, Takeda Pharmaceutical entered into a partnership with Frazier Healthcare to form a new biopharmaceutical company named HilleVax, in June 2021.

Challenges

Stringent regulations and high capital investment

The biopharmaceutical market is regulated by the stringent government norms and regulations. Furthermore, a high initial capital investment is required to establish a biopharmaceutical company. Moreover, further investments are involved in the research, development, clinical trials, and approval of the newly developed medicines. Hence, huge capital requirement and stringent government regulations are the major concern for the market players.

Report Highlights

  • Based on the type, the monoclonal antibodies segment dominated the market in 2020. The increased efficacy of the monoclonal antibodies to specifically target the affected cell and treat that cell without harming the normal cells results in the low or minimal side-effects. This is a major factor that has propelled the demand for the monoclonal antibodies for the treatment of various chronic diseases like cancer.
  • Based on the application, the oncology segment dominated the global biopharmaceutical market in 2020. This is attributable to the increased adoption of the biopharmaceuticals in the treatment of various cancer like breast cancer, lungs cancer, and prostate cancer. The increased prevalence of cancer among the population is boosting the market growth.According to the International Agency for Research on Cancer, in the year 2020, around 19.3 million new cases of cancer were diagnosed and this number is expected to grow by 47% from 2020 to 2040.

Regional Snapshot

North America dominated the global biopharmaceutical market in 2020. The increased prevalence of various chronic diseases in the US and growing geriatric population has fueled the demand for the biopharmaceuticals. As per the American Cancer Society, around 1.8 million new cancer cases were reported in US in 2020. Moreover, the FDA plays a crucial role in the market growth of the biopharmaceutical market. The FDA approved 53 new novel drugs in 2020. The increased investments by the market players in the research and development of the new drugs and their clinical trials is expected to provide lucrative growth opportunities to the market players. Moreover, the increased government investments to develop the biopharmaceutical industry in US has significant contributions in the development of the North American market. US holds the property rights of the majority of the new drugs developed recently. North America is projected to stay dominant throughout the forecast period.

Asia Pacific is estimated to be the most opportunistic market during the forecast period. The countries like China, India, and South Korea are increasing their efforts in the development of the biopharmaceutical industry and attracting FDIs owing to the presence of cheap factors of production. The presence of few world’s top contract manufacturing organizations in Asia Pacific has significantly driven the growth of the biopharmaceutical market. Further rising prevalence of various chronic diseases and growing geriatric population in the region is presenting growth avenues to the market players. According to the WHO, 80% of the global geriatric population is expected to be living in the low and middle income countries. Furthermore, the rising awareness among the population regarding the biopharmaceuticals is expected to foster the demand for the biopharmaceuticals in the region in the forthcoming years.

Market Segmentation

By Type

  • Monoclonal Antibodies
  • Insulin
  • Vaccine
  • Hormone
  • Interferon
  • Erythropoietin
  • Growth & Coagulation Factor
  • Others

By Application

  • Blood Disorder
  • Oncology
  • Infectious Disease
  • Neurological Disease
  • Cardiovascular Disease
  • Metabolic Disease
  • Immunology
  • Others

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Why should you invest in this report?

If you are aiming to enter the global biopharmaceutical market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for biopharmaceutical are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1422

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biopharmaceutical Market 

5.1. COVID-19 Landscape: Biopharmaceutical Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biopharmaceutical Market, By Type

8.1. Biopharmaceutical Market, by Type, 2021-2030

8.1.1. Monoclonal Antibodies

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Insulin

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Vaccine

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Hormone

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Interferon

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Erythropoietin

8.1.6.1. Market Revenue and Forecast (2019-2030)

8.1.7. Growth & Coagulation Factor

8.1.7.1. Market Revenue and Forecast (2019-2030)

8.1.8. Others

8.1.8.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Biopharmaceutical Market, By Application

9.1. Biopharmaceutical Market, by Application, 2021-2030

9.1.1. Blood Disorder

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Oncology

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Infectious Disease

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Neurological Disease

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Cardiovascular Disease

9.1.5.1. Market Revenue and Forecast (2019-2030)

9.1.6. Metabolic Disease

9.1.6.1. Market Revenue and Forecast (2019-2030)

9.1.7. Immunology

9.1.7.1. Market Revenue and Forecast (2019-2030)

9.1.8. Others

9.1.8.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Biopharmaceutical Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

Chapter 11. Company Profiles

11.1. Abbott Laboratories

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Amgen, Inc.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Biogen, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Eli Lilly and Company

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. F. Hoffmann-La Roche, Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Johnson & Johnson

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Merck & Co., Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Novo Nordisk A/S

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Pfizer, Inc.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Sanofi

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1422

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Read Also:

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button